Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 69,190 | 48,155 | -25,002 | 71,517 | 26,752 |
| Depreciation Amortization | 167,132 | 148,021 | 138,939 | 68,917 | 61,550 |
| Income taxes - deferred | -26,814 | -2,153 | -8,391 | -78,042 | 0 |
| Accounts receivable | -4,414 | 3,594 | -21,780 | -22,524 | -10,367 |
| Accounts payable and accrued liabilities | -11,278 | 5,061 | -707 | -5,827 | 3,769 |
| Other Working Capital | -54,978 | 21,731 | -12,713 | 13,486 | -25,299 |
| Other Operating Activity | 66,142 | 50,340 | 53,884 | 56,030 | 37,537 |
| Operating Cash Flow | $204,980 | $274,749 | $124,230 | $103,557 | $93,942 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 92,602 | 22,000 | N/A | N/A | N/A |
| PPE Investments | -1,652 | -461 | -1,622 | -1,944 | -5,546 |
| Net Acquisitions | -267,538 | N/A | -572,069 | N/A | N/A |
| Purchase Of Investment | -111,171 | -92,351 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -368,226 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -368,226 |
| Investing Cash Flow | $-287,759 | $-70,812 | $-573,691 | $-1,944 | $-373,772 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 313,175 | 235,220 | 517,682 | N/A | 330,394 |
| Debt Repayment | -141,058 | -301,138 | -75,000 | -50,000 | -49,000 |
| Common Stock Issued | 11,073 | 9,101 | 12,148 | 12,707 | 7,335 |
| Common Stock Repurchased | -60,025 | -75,000 | -14,063 | -47,861 | 0 |
| Other Financing Activity | -183,768 | -8,361 | -4,044 | -4,149 | -2,255 |
| Financing Cash Flow | $-60,603 | $-140,178 | $436,723 | $-89,303 | $286,474 |
| Beginning Cash Position | 239,994 | 176,235 | 188,973 | 176,663 | 170,019 |
| End Cash Position | 96,612 | 239,994 | 176,235 | 188,973 | 176,663 |
| Net Cash Flow | $-143,382 | $63,759 | $-12,738 | $12,310 | $6,644 |
| Free Cash Flow | |||||
| Operating Cash Flow | 204,980 | 274,749 | 124,230 | 103,557 | 93,942 |
| Capital Expenditure | -1,652 | -461 | -1,622 | -1,944 | -5,546 |
| Free Cash Flow | 203,328 | 274,288 | 122,608 | 101,613 | 88,396 |